References
- Kiyotani K , UnoS, MushirodaT et al. A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy. Pharmacogenet. Genomics 22(4) , 229–235 (2012).
- Soo RA , YongWP, InnocentiF. Systemic therapies for pancreatic cancer – the role of pharmacogenetics. Curr. Drug Targets13(6) , 811–828 (2012).
- Ciccolini J , MercierC, DahanL, AndréN.Integrating pharmacogenetics into gemcitabine dosing – time for a change? Nat. Rev. Clin. Oncol.8(7) , 439–444 (2011).
- Wong A , SooRA, YongWP, InnocentiF.Clinical pharmacology and pharmacogenetics of gemcitabine. Drug Metab. Rev.41(2) , 77–88 (2009).
- SEARCH Collaborative Group; Link E, Parish S, Armitage J et al.SLCO1B1 variants and statin-induced myopathy – a genomewide study. N. Engl. J. Med.359(8) , 789–799 (2008).
- Huppi K , PittJJ, WahlbergBM, CaplenNJ. The 8q24 gene desert: an oasis of non-coding transcriptional activity. Front. Genet.3 , 69 (2012).
- Gamazon ER , SkolAD, PereraMA. The limits of genome-wide methods for pharmacogenomic testing. Pharmacogenet. Genomics22(4) , 261–272 (2012).
- Innocenti F , OwzarK, CoxNL et al. A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303. Clin. Cancer Res. 18(2) , 577–584 (2012).
References
- Innocenti F , SchilskyRL. Translating the cancer genome into clinically useful tools and strategies. Dis. Model Mech.2(9–10) , 426–429 (2009).
- Dai J , GuJ, HuangM et al. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes. Carcinogenesis doi:10.1093/carcin/bgs147 (2012) (Epub ahead of print).
- Chung CC , ChanockSJ. Current status of genome-wide association studies in cancer. Hum. Genet.130(1) , 59–78 (2011).
- Wiklund F . Prostate cancer genomics: can we distinguish between indolent and fatal disease using genetic markers? Genome Med.2(7) , 45 (2010).
- Tuupanen S , TurunenM, LehtonenR et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 41(8) , 885–890 (2009).